ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Youth-Nominated Support Team Intervention for Suicidal Adolescents

This study has been completed.

Sponsored by: National Institute of Mental Health (NIMH)
Information provided by: National Institute of Mental Health (NIMH)
ClinicalTrials.gov Identifier: NCT00071617
  Purpose

This study will attempt to improve treatment adherence and reduce suicide risk among adolescents who are at risk for attempting suicide.


Condition Intervention Phase
Suicide, Attempted
Behavioral: Youth-Nominated Support Team
Phase II

MedlinePlus related topics:   Suicide   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title:   Youth Support Team Intervention for Suicidal Adolescents

Further study details as provided by National Institute of Mental Health (NIMH):

Estimated Enrollment:   532
Study Start Date:   November 2002
Study Completion Date:   December 2006

Detailed Description:

Despite substantial knowledge about adolescent suicide risk factors, few studies have been conducted to identify effective interventions for suicidal adolescents.

Youth-Nominated Support Team (YST) is an intervention designed to help suicidal adolescents after hospitalization. It is a psychoeducational social network intervention that targets poor treatment adherence and difficulties with social support. YST is designed to be a supplement to traditional or usual treatments.

Participants are randomly assigned to receive either treatment as usual (TAU) or TAU plus YST for 3 months. Adolescents who receive TAU plus YST nominate three or four adults from their family, school, and community settings to function as support persons. The support persons participate in a psychoeducation session that focuses on the adolescent's psychiatric disorder(s), individualized treatment plan, importance of treatment adherence, and suicide risk factors. They also maintain regular contact with the adolescent to support treatment adherence and progress toward treatment goals. Adolescents have assessments at 6 weeks, 3 months, 6 months, and 12 months. Internalizing behavior problems, perceived social support, treatment adherence, adaptive functioning, severity of depression and anxiety, severity and frequency of suicidal thoughts, and suicide attempts are assessed.

  Eligibility
Ages Eligible for Study:   13 Years to 17 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • Hospitalization in a participating psychiatric facility
  • Suicidal ideation, intent, or attempt

Exclusion Criteria:

  • Severe physical or cognitive impairment that makes informed consent, nominations, or participation in assessments impossible
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00071617

Locations
United States, Michigan
Child and Adolescent Psychiatry Hospital, University of Michigan    
      Ann Arbor, Michigan, United States, 48109

Sponsors and Collaborators

Investigators
Principal Investigator:     Cheryl A. King, Ph.D.     University of Michigan    
  More Information


Related Info  This link exits the ClinicalTrials.gov site
 

Study ID Numbers:   R01 MH63881, DSIR 84-CTS
First Received:   October 29, 2003
Last Updated:   December 10, 2007
ClinicalTrials.gov Identifier:   NCT00071617
Health Authority:   United States: Federal Government

Keywords provided by National Institute of Mental Health (NIMH):
Suicide  
Adolescence  

Study placed in the following topic categories:
Suicide, Attempted
Suicide
Behavioral Symptoms
Self-Injurious Behavior

ClinicalTrials.gov processed this record on November 30, 2008




Links to all studies - primarily for crawlers